0

FDA Issues Warning Letter to Company that Sells CBD Products Online and Through Social Media

FDA sends warning letter to a company because its website and social media accounts made claims about CBD products that suggest they are drugs or dietary supplements and were misbranded.

0

The FDA’s Frequently Asked Questions about the Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD) – Part Two

More FDA answers to questions about cannabis-derived CBD drugs, foods, dietary supplements and food products including access to CBD for clinical investigations.

0

The FDA Frequently Asked Questions about the Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)

Questions and answers by the Food and Drug Administration regarding the regulation of CBD products for medical uses, for drug uses, use as dietary supplements, and for other uses.

0

Before You Overpromise the Benefits of CBD, Know that the FTC is Watching

Both the FTC and FDA are reviewing your web and print marketing materials. If you make unsupported medical and treatment claims about your CBD promotions, you will receive a warning letter.

0

Why Companies are Rushing to Make and Sell Products with CBD and THC

Makers and consumers of THC and CBD products need to understand which federal and state laws apply. While there may be health benefits, there are legal risks.